Myriad Asset Management Ltd.

Holdings History for NEUROCRINE BIOSCIENCES INC - NOTE 2.250% 5/1

Investment type: Debt / NOTE 2.250% 5/1

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Principal	Change	Activity %	Price	All Holders
31 Mar 2020		-2.3%	$0	0	-12,000,000	-100%		Q1 2020
31 Dec 2019	2.3%	+2.3%	$18,375,000	12,000,000	+12,000,000	NEW	153.13%	Q4 2019
31 Dec 2018		-4.3%	$0	0	-17,500,000	-100%		Q4 2018
30 Sep 2018	4.3%	+0.49%	$29,890,000	17,500,000	+2,000,000	+13%	170.8%	Q3 2018
30 Jun 2018	3.1%	+3.1%	$22,520,000	15,500,000	+15,500,000	NEW	145.29%	Q2 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.